≥2 ARMS/GROUPS: DICHOTOMOUS OUTCOMES (e.g. OR, RR, %death)

Covariates: age, gender

UI Author Year Outcome Exposure Categories(e.g., Tertiles)/Intervention Groups Mean Vit D level/dose Mean Ca level/dose No. of Cases (Event) * No. of Non-cases N ** Mean Follow-up, mo Crude or Adjusted analysis? Outcome Metric (e.g. OR, RR, HR, %) Outcome effect size CI ** P between groups *** P for trend ****
12020102 Martinez 2002 Adenoma recurrence 1 st total calcium intake quartile (mg/day) < 778 178 148 36.8 adjusted OR 1.00 0.002
Adenoma recurrence 2 nd total calcium intake quartile (mg/day) 778–996 175 151 36.8 adjusted OR 0.90 0.66–1.23 nd
Adenoma recurrence 3 rd total calcium intake quartile (mg/day) 997–1279 148 178 36.8 adjusted OR 0.64 0.47–0.88 nd
Adenoma recurrence 4 th total calcium intake quartile(mg/day) >1279 138 188 36.8 adjusted OR 0.65 0.47–0.90 nd

Duplicate one row per exposure category or intervention group.

*

Number of subjects with outcome

**

Please choose one and delete the others

***

Specify the comparison. For example group 1 vs. 3 = −6; group 1 vs. 2 = −8

****

P value for testing the linear trend of the OR/RR across different categories or doses

Number of subjects with outcome

Please choose one and delete the others

Specify the comparison. For example group 1 vs. 3 = −6; group 1 vs. 2 = −8

P value for testing the linear trend of the OR/RR across different categories or doses

From: Appendix C, Evidence Tables: L-Q

Cover of Vitamin D and Calcium
Vitamin D and Calcium: A Systematic Review of Health Outcomes.
Evidence Reports/Technology Assessments, No. 183.
Chung M, Balk EM, Brendel M, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.